User profiles for A. M. Spivak

Adam M. Spivak, MD

University of Utah School of Medicine
Verified email at hsc.utah.edu
Cited by 3600

Urinary tract infections: current and emerging management strategies

AE Barber, JP Norton, AM Spivak… - Clinical infectious …, 2013 - academic.oup.com
Acute cystitis is one of the most commonly encountered bacterial infections and is responsible
for substantial morbidity and high medical costs in the United States and across the globe. …

Novel latency reversal agents for HIV-1 cure

AM Spivak, V Planelles - Annual review of medicine, 2018 - annualreviews.org
Antiretroviral therapy (ART) has rendered HIV-1 infection a treatable illness; however, ART
is not curative owing to the persistence of replication-competent, latent proviruses in long-…

Recommendations for measuring HIV reservoir size in cure-directed clinical trials

…, F Bushman, JD Siliciano, MR Betts, AM Spivak… - Nature medicine, 2020 - nature.com
Therapeutic strategies are being clinically tested either to eradicate latent HIV reservoirs or
to achieve virologic control in the absence of antiretroviral therapy. Attaining this goal will …

[HTML][HTML] No evidence of severe acute respiratory syndrome–coronavirus 2 in semen of males recovering from coronavirus disease 2019

…, X Xiao, J Guo, Y Song, H Li, DP Patel, AM Spivak… - Fertility and sterility, 2020 - Elsevier
Objective To describe detection of severe acute respiratory syndrome (SARS)–coronavirus
2 (CoV-2) in seminal fluid of patients recovering from coronavirus disease 2019 (COVID-19) …

A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1–infected adults on antiretroviral therapy

AM Spivak, A Andrade, E Eisele, R Hoh… - Clinical infectious …, 2014 - academic.oup.com
Background. Transcriptionally silent human immunodeficiency virus type 1 (HIV-1) DNA
persists in resting memory CD4 + T cells despite antiretroviral therapy. In a primary cell model, …

[PDF][PDF] BIRC2/cIAP1 is a negative regulator of HIV-1 transcription and can be targeted by Smac mimetics to promote reversal of viral latency

L Pache, MS Dutra, AM Spivak, JM Marlett, JP Murry… - Cell host & …, 2015 - cell.com
Combination antiretroviral therapy (ART) is able to suppress HIV-1 replication to undetectable
levels. However, the persistence of latent viral reservoirs allows for a rebound of viral load …

[HTML][HTML] A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation

…, ER Duke, TA Wagner, SE Palmer, AM Spivak… - Nature …, 2018 - nature.com
Antiretroviral therapy (ART) suppresses viral replication in people living with HIV. Yet, infected
cells persist for decades on ART and viremia returns if ART is stopped. Persistence has …

CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells

…, J Grau-Exposito, AM Spivak… - Science translational …, 2018 - science.org
… , AM Spivak). Total CD4 + T cells were purified via negative magnetic bead selection
using a total CD4 + T cell–negative isolation kit (STEMCELL) according to the manufacturer’s …

HIV-1 eradication: early trials (and tribulations)

AM Spivak, V Planelles - Trends in molecular medicine, 2016 - cell.com
Antiretroviral therapy (ART) has rendered HIV-1 infection a manageable illness for those
with access to treatment. However, ART does not lead to viral eradication owing to the …

Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4+ T Cells from Aviremic Patients

AM Spivak, A Bosque, AH Balch, D Smyth… - Antimicrobial agents …, 2015 - Am Soc Microbiol
The human immunodeficiency virus type 1 (HIV-1) latent reservoir in resting CD4 + T cells
represents a major barrier to viral eradication. Small compounds capable of latency reversal …